Lipopolysaccharide	Lipopolysaccharide	NN	B-NP	O		0	18
from	from	IN	B-PP	O		19	23
nonvirulent	nonvirulent	JJ	B-NP	O		24	35
Ara+	Ara+	NNP	I-NP	O		36	40
Burkholderia pseudomallei	Burkholderia_pseudomallei	NNP	I-NP	O		41	66
isolates	isolate	VBZ	B-VP	O		67	75
is	be	VBZ	B-VP	O		76	78
immunologically	immunologically	RB	B-ADJP	O		79	94
indistinguishable	indistinguishable	JJ	I-ADJP	O		95	112
from	from	IN	B-PP	O		113	117
lipopolysaccharide	lipopolysaccharide	NN	B-NP	O		118	136
from	from	IN	B-PP	O		137	141
virulent	virulent	JJ	B-NP	O		142	150
Ara	Ara	NNP	I-NP	O		151	154
-	-	HYPH	I-NP	O		154	155
clinical	clinical	JJ	I-NP	O		156	164
isolates	isolate	NNS	I-NP	O		165	173
.	.	.	O	O		173	174

Different	Different	JJ	B-NP	O		175	184
lines	line	NNS	I-NP	O		185	190
of	of	IN	B-PP	O		191	193
evidence	evidence	NN	B-NP	O		194	202
suggest	suggest	VBP	B-VP	O		203	210
that	that	IN	B-SBAR	O		211	215
a	a	DT	B-NP	O		216	217
discrepancy	discrepancy	NN	I-NP	O		218	229
between	between	IN	B-PP	O		230	237
the	the	DT	B-NP	O		238	241
distribution	distribution	NN	I-NP	O		242	254
of	of	IN	B-PP	O		255	257
Burkholderia	Burkholderia	NNP	B-NP	O		258	270
(	(	(	O	O		271	272
Pseudomonas	Pseudomonas	NNP	B-NP	O		272	283
)	)	)	O	O		283	284
pseudomallei	pseudomallei	NNS	B-NP	O		285	297
in	in	IN	B-PP	O		298	300
the	the	DT	B-NP	O		301	304
environment	environment	NN	I-NP	O		305	316
and	and	CC	O	O		317	320
the	the	DT	B-NP	O		321	324
distribution	distribution	NN	I-NP	O		325	337
of	of	IN	B-PP	O		338	340
the	the	DT	B-NP	O		341	344
disease	disease	NN	I-NP	O		345	352
melioidosis	melioidosis	NN	I-NP	O		353	364
is	be	VBZ	B-VP	O		365	367
attributable	attributable	JJ	B-ADJP	O		368	380
,	,	,	O	O		380	381
at	at	IN	B-ADVP	O		382	384
least	least	JJS	I-ADVP	O		385	390
in	in	IN	B-PP	O		391	393
part	part	NN	B-NP	O		394	398
,	,	,	O	O		398	399
to	to	TO	B-PP	O		400	402
phenotypic	phenotypic	JJ	B-NP	O		403	413
differences	difference	NNS	I-NP	O		414	425
between	between	IN	B-PP	O		426	433
clinical	clinical	JJ	O	O		434	442
and	and	CC	O	O		443	446
some	some	DT	B-NP	O		447	451
environmental	environmental	JJ	I-NP	O		452	465
isolates	isolate	NNS	I-NP	O		466	474
.	.	.	O	O		474	475

Two	Two	CD	B-NP	O		476	479
antigenically	antigenically	RB	I-NP	O		480	493
and	and	CC	O	O		494	497
biochemically	biochemically	RB	B-NP	O		498	511
distinct	distinct	JJ	I-NP	O		512	520
biotypes	biotype	NNS	I-NP	O		521	529
have	have	VBP	B-VP	O		530	534
been	be	VBN	I-VP	O		535	539
described	describe	VBN	I-VP	O		540	549
,	,	,	O	O		549	550
only	only	RB	B-NP	O		551	555
one	one	CD	I-NP	O		556	559
of	of	IN	B-PP	O		560	562
which	which	WDT	B-NP	O		563	568
is	be	VBZ	B-VP	O		569	571
virulent	virulent	JJ	B-ADJP	O		572	580
.	.	.	O	O		580	581

In	In	IN	B-PP	O		582	584
this	this	DT	B-NP	O		585	589
study	study	NN	I-NP	O		590	595
,	,	,	O	O		595	596
lipopolysaccharides	lipopolysaccharide	NNS	B-NP	O		597	616
(	(	(	O	O		617	618
LPSs	LPS	NNS	B-NP	O		618	622
)	)	)	O	O		622	623
were	be	VBD	B-VP	O		624	628
extracted	extract	VBN	I-VP	O		629	638
by	by	IN	B-PP	O		639	641
the	the	DT	B-NP	O		642	645
proteinase	proteinase	NN	I-NP	O		646	656
K	K	NN	I-NP	O		657	658
digestion	digestion	NN	I-NP	O		659	668
method	method	NN	I-NP	O		669	675
from	from	IN	B-PP	O		676	680
a	a	DT	B-NP	O		681	682
total	total	NN	I-NP	O		683	688
of	of	IN	B-PP	O		689	691
214	214	CD	B-NP	O		692	695
B. pseudomallei	B._pseudomallei	NNP	I-NP	O		696	711
isolates	isolate	NNS	I-NP	O		712	720
,	,	,	O	O		720	721
and	and	CC	O	O		722	725
their	their	PRP$	B-NP	O		726	731
immunoreactivities	immunoreactivity	NNS	I-NP	O		732	750
with	with	IN	B-PP	O		751	755
sera	serum	NNS	B-NP	O		756	760
from	from	IN	B-PP	O		761	765
patients	patient	NNS	B-NP	O		766	774
with	with	IN	B-PP	O		775	779
different	different	JJ	B-NP	O		780	789
clinical	clinical	JJ	I-NP	O		790	798
spectra	spectrum	NNS	I-NP	O		799	806
and	and	CC	B-PP	O		807	810
with	with	IN	B-PP	O		811	815
other	other	JJ	B-NP	O		816	821
infections	infection	NNS	I-NP	O		822	832
were	be	VBD	B-VP	O		833	837
evaluated	evaluate	VBN	I-VP	O		838	847
.	.	.	O	O		847	848

With	With	IN	B-PP	O		849	853
the	the	DT	B-NP	O		854	857
exception	exception	NN	I-NP	O		858	867
of4	of4	NN	I-NP	O		868	871
isolates	isolate	NNS	I-NP	O		872	880
from	from	IN	B-PP	O		881	885
a	a	DT	B-NP	O		886	887
total	total	NN	I-NP	O		888	893
of	of	IN	B-PP	O		894	896
214	214	CD	B-NP	O		897	900
tested	test	VBN	B-VP	O		901	907
,	,	,	O	O		907	908
the	the	DT	B-NP	O		909	912
sodium	sodium	NN	I-NP	O		913	919
dodecyl	dodecyl	NN	I-NP	O		920	927
sulfate	sulfate	NN	I-NP	O		928	935
-	-	HYPH	B-NP	O		935	936
polyacrylamide	polyacrylamide	NN	I-NP	O		936	950
gel	gel	NN	I-NP	O		951	954
electrophoresis	electrophoresis	NN	I-NP	O		955	970
silver	silver	NN	I-NP	O		971	977
-	-	HYPH	O	O		977	978
staining	stain	VBG	B-VP	O		978	986
profiles	profile	NNS	B-NP	O		987	995
of	of	IN	B-PP	O		996	998
the	the	DT	B-NP	O		999	1002
LPSs	LPS	NNS	I-NP	B-DNA		1003	1007
from	from	IN	B-PP	O		1008	1012
the	the	DT	B-NP	O		1013	1016
two	two	CD	I-NP	O		1017	1020
biotypes	biotype	NNS	I-NP	O		1021	1029
showed	show	VBD	B-VP	O		1030	1036
identical	identical	JJ	B-NP	O		1037	1046
ladder	ladder	NN	I-NP	O		1047	1053
patterns	pattern	NNS	I-NP	O		1054	1062
that	that	WDT	B-NP	O		1063	1067
were	be	VBD	B-VP	O		1068	1072
typical	typical	JJ	B-ADJP	O		1073	1080
for	for	IN	B-PP	O		1081	1084
smooth	smooth	JJ	B-NP	O		1085	1091
LPSs	LPS	NNS	I-NP	O		1092	1096
from	from	IN	B-PP	O		1097	1101
other	other	JJ	B-NP	O		1102	1107
gram	gram	NN	I-NP	O		1108	1112
-	-	HYPH	B-NP	O		1112	1113
negative	negative	JJ	I-NP	O		1113	1121
bacteria	bacteria	NNS	I-NP	O		1122	1130
.	.	.	O	O		1130	1131

The	The	DT	B-NP	O		1132	1135
210	210	CD	I-NP	O		1136	1139
isolates	isolate	NNS	I-NP	O		1140	1148
with	with	IN	B-PP	O		1149	1153
typical	typical	JJ	B-NP	O		1154	1161
LPS	LPS	NN	I-NP	O		1162	1165
patterns	pattern	NNS	I-NP	O		1166	1174
(	(	(	O	O		1175	1176
119	119	CD	B-NP	O		1176	1179
Ara	Ara	NNP	I-NP	O		1180	1183
-	-	HYPH	I-NP	O		1183	1184
clinical	clinical	JJ	I-NP	O		1185	1193
,	,	,	O	O		1193	1194
13	13	CD	B-NP	O		1195	1197
Ara	Ara	NNP	I-NP	O		1198	1201
-	-	HYPH	I-NP	O		1201	1202
soil	soil	NN	I-NP	O		1203	1207
,	,	,	O	O		1207	1208
70	70	CD	B-NP	O		1209	1211
Ara+	Ara+	JJ	I-NP	O		1212	1216
soil	soil	NN	I-NP	O		1217	1221
,	,	,	O	O		1221	1222
and	and	CC	O	O		1223	1226
8	8	CD	B-NP	O		1227	1228
reference	reference	NN	I-NP	O		1229	1238
National	National	NNP	I-NP	O		1239	1247
Type	Type	NNP	I-NP	O		1248	1252
Culture	Culture	NNP	I-NP	O		1253	1260
Collection	Collection	NNP	I-NP	O		1261	1271
strains	strain	NNS	I-NP	O		1272	1279
)	)	)	O	O		1279	1280
also	also	RB	B-ADVP	O		1281	1285
exhibited	exhibit	VBD	B-VP	O		1286	1295
similar	similar	JJ	B-NP	O		1296	1303
immunoblot	immunoblot	NN	I-NP	O		1304	1314
profiles	profile	NNS	I-NP	O		1315	1323
against	against	IN	B-PP	O		1324	1331
pooled	pooled	JJ	B-NP	O		1332	1338
sera	serum	NNS	I-NP	O		1339	1343
from	from	IN	B-PP	O		1344	1348
patients	patient	NNS	B-NP	O		1349	1357
with	with	IN	B-PP	O		1358	1362
melioidosis	melioidosis	NN	B-NP	O		1363	1374
and	and	CC	O	O		1375	1378
hyperimmune	hyperimmune	JJ	B-NP	O		1379	1390
mouse	mouse	NN	I-NP	O		1391	1396
sera	serum	NNS	I-NP	O		1397	1401
.	.	.	O	O		1401	1402

Concordant	Concordant	JJ	B-NP	O		1403	1413
findings	finding	NNS	I-NP	O		1414	1422
were	be	VBD	B-VP	O		1423	1427
noted	note	VBN	I-VP	O		1428	1433
in	in	IN	B-PP	O		1434	1436
the	the	DT	B-NP	O		1437	1440
indirect	indirect	JJ	I-NP	O		1441	1449
enzyme	enzyme	NN	I-NP	O		1450	1456
-	-	HYPH	B-VP	O		1456	1457
linked	link	VBN	B-NP	O		1457	1463
immunosorbent	immunosorbent	NN	I-NP	O		1464	1477
assay	assay	NN	I-NP	O		1478	1483
with	with	IN	B-PP	O		1484	1488
Ara	Ara	NN	B-NP	B-protein		1489	1492
-	-	HYPH	B-NP	O		1492	1493
and	and	CC	I-NP	O		1494	1497
Ara+	Ara+	JJ	I-NP	O		1498	1502
LPSs	LPS	NNS	I-NP	O		1503	1507
to	to	TO	B-VP	O		1508	1510
coat	coat	VB	I-VP	O		1511	1515
the	the	DT	B-NP	O		1516	1519
microtiter	microtiter	NN	I-NP	O		1520	1530
plates	plat	VBZ	B-VP	O		1531	1537
.	.	.	O	O		1537	1538

The	The	DT	B-NP	O		1539	1542
LPSs	LPS	NNS	I-NP	O		1543	1547
of	of	IN	B-PP	O		1548	1550
the	the	DT	B-NP	O		1551	1554
different	different	JJ	I-NP	O		1555	1564
B. pseudomallei	B._pseudomallei	NNP	I-NP	O		1565	1580
biotypes	biotype	NNS	I-NP	O		1581	1589
appear	appear	VBP	B-VP	O		1590	1596
antigenically	antigenically	RB	B-ADJP	O		1597	1610
indistinguishable	indistinguishable	JJ	I-ADJP	O		1611	1628
.	.	.	O	O		1628	1629

It	It	PRP	B-NP	O		1630	1632
is	be	VBZ	B-VP	O		1633	1635
,	,	,	O	O		1635	1636
therefore	therefore	RB	B-ADVP	O		1637	1646
,	,	,	O	O		1646	1647
unlikely	unlikely	JJ	B-ADJP	O		1648	1656
that	that	IN	B-SBAR	O		1657	1661
this	this	DT	B-NP	O		1662	1666
component	component	NN	I-NP	O		1667	1676
is	be	VBZ	B-VP	O		1677	1679
related	related	JJ	B-ADJP	O		1680	1687
to	to	TO	B-PP	O		1688	1690
the	the	DT	B-NP	O		1691	1694
virulence	virulence	NN	I-NP	O		1695	1704
and	and	CC	I-NP	O		1705	1708
pathogenicity	pathogenicity	NN	I-NP	O		1709	1722
of	of	IN	B-PP	O		1723	1725
B. pseudomallei	B._pseudomallei	NNP	B-NP	O		1726	1741
.	.	.	O	O		1741	1742

